These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21666174)

  • 41. The global burden of measles in the year 2000--a model that uses country-specific indicators.
    Stein CE; Birmingham M; Kurian M; Duclos P; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S8-14. PubMed ID: 12721886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cost-benefit analysis of a national immunization program against measles in Mexico].
    Vargas Flores LA; Núñez Gomiciaga E
    Salud Publica Mex; 1984; 26(4):373-80. PubMed ID: 6435263
    [No Abstract]   [Full Text] [Related]  

  • 43. Progress towards elimination of measles in the Americas. WHO expanded programme on immunization.
    Can Commun Dis Rep; 1998 Jun; 24(11):94-6. PubMed ID: 9629836
    [No Abstract]   [Full Text] [Related]  

  • 44. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Bellagio consensus. Children's Vaccine Initiative Ad Hoc Committe on an Investment Strategy for Measles Control.
    J Infect Dis; 1994 Nov; 170 Suppl 1():S63-6. PubMed ID: 7930755
    [No Abstract]   [Full Text] [Related]  

  • 46. Interruption of indigenous measles transmission in Bolivia since October 2000.
    Quiroga R; Barrezueta O; Venczel L; Halkyer P; Gil F; Machicao E; Landaverde M; Quiñonez A; Izurieta H
    J Infect Dis; 2003 May; 187 Suppl 1():S121-6. PubMed ID: 12721902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008.
    Weldegebriel GG; Gasasira A; Harvey P; Masresha B; Goodson JL; Pate MA; Abanida E; Chevez A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S226-31. PubMed ID: 21666165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measles epidemiology and outbreak response immunization in a rural community in Peru.
    Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC
    Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Health impact of measles vaccination in the United States.
    Bloch AB; Orenstein WA; Stetler HC; Wassilak SG; Amler RW; Bart KJ; Kirby CD; Hinman AR
    Pediatrics; 1985 Oct; 76(4):524-32. PubMed ID: 3931045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of supplementary immunization for measles in India.
    Dabral M
    Indian Pediatr; 2009 Nov; 46(11):957-62. PubMed ID: 19578225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Review of the effect of measles vaccination on the epidemiology of SSPE.
    Campbell H; Andrews N; Brown KE; Miller E
    Int J Epidemiol; 2007 Dec; 36(6):1334-48. PubMed ID: 18037676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progress toward the 2012 measles elimination goal--Western Pacific Region, 1990-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jun; 58(24):669-73. PubMed ID: 19553903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progress in global measles control and mortality reduction, 2000-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Nov; 56(47):1237-41. PubMed ID: 18046301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update: global measles control and mortality reduction--worldwide, 1991-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 May; 52(20):471-5. PubMed ID: 12807081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elimination of measles--South Korea, 2001-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Apr; 56(13):304-7. PubMed ID: 17410083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparing measles with previous eradication programs: enabling and constraining factors.
    Keegan R; Dabbagh A; Strebel PM; Cochi SL
    J Infect Dis; 2011 Jul; 204 Suppl 1():S54-61. PubMed ID: 21666211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accelerated measles control--Cambodia, 1999-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jan; 52(1):4-6. PubMed ID: 12549899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Economic analysis of investment priorities for measles control.
    Shepard DS
    J Infect Dis; 1994 Nov; 170 Suppl 1():S56-62. PubMed ID: 7930754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program.
    Babigumira JB; Levin A; Burgess C; Garrison LP; Bauch CT; Braka F; Mbabazi WB; Nabyonga JO; Simons E; Dabbagh A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S116-23. PubMed ID: 21666152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.